AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55,968 | +4758.3% | 19,638 | +4935.4% | 0.00% | – |
Q2 2023 | $1,152 | +115100.0% | 390 | -29.5% | 0.00% | – |
Q1 2023 | $1 | -100.0% | 553 | -83.4% | 0.00% | – |
Q3 2022 | $11,000 | +22.2% | 3,334 | +38.2% | 0.00% | – |
Q2 2022 | $9,000 | -70.0% | 2,412 | -68.5% | 0.00% | – |
Q1 2022 | $30,000 | +7.1% | 7,657 | +39.4% | 0.00% | – |
Q4 2021 | $28,000 | -62.7% | 5,491 | -50.9% | 0.00% | -100.0% |
Q3 2021 | $75,000 | +316.7% | 11,191 | +404.3% | 0.00% | – |
Q2 2021 | $18,000 | -52.6% | 2,219 | -55.5% | 0.00% | -100.0% |
Q1 2021 | $38,000 | +11.8% | 4,988 | -24.7% | 0.00% | 0.0% |
Q4 2020 | $34,000 | +3.0% | 6,625 | -2.4% | 0.00% | – |
Q3 2020 | $33,000 | -26.7% | 6,788 | +0.2% | 0.00% | -100.0% |
Q2 2020 | $45,000 | – | 6,774 | +56350.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 12 | -99.9% | 0.00% | -100.0% |
Q4 2019 | $75,000 | +21.0% | 8,740 | -29.8% | 0.01% | +50.0% |
Q3 2019 | $62,000 | +51.2% | 12,454 | +52.5% | 0.00% | +100.0% |
Q1 2019 | $41,000 | +28.1% | 8,164 | +103.2% | 0.00% | 0.0% |
Q3 2018 | $32,000 | +357.1% | 4,018 | +631.9% | 0.00% | +100.0% |
Q4 2017 | $7,000 | -74.1% | 549 | -82.0% | 0.00% | -66.7% |
Q2 2017 | $27,000 | – | 3,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
PA Capital LLC | 76,257 | $377,000 | 0.37% |
Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |